See if you or your loved one may qualify

Can my loved one or I join the ILLUMINATE Study?

All clinical studies have a criteria (called inclusion and exclusion criteria) that people must meet in order to take part. These are important for a number of reasons, including the safety of the study participants, but also to support accuracy of the study data and to be in line with laws and regulations and the rules of health authorities.

To learn if you or your loved one may meet the entry criteria for the ILLUMINATE Study, please complete this short questionnaire.

 Is your loved one between 5 and 35 years of age?
 Does your loved one weigh 12 kg (i.e. 26 pounds) or more?
 Has your loved one been diagnosed with Rett syndrome that is caused by a mutation in the MECP2 gene?
 Is your loved one currently taking more than 4 daily anti-seizure medications (not counting rescue medications)?
 Has your loved one been treated with fenfluramine hydrochloride (Fintepla®) in the past?
 Can your loved one swallow medications as a liquid solution or receive them via a gastrostomy tube (G-tube)?

We value your Privacy

This UCB website uses cookies. Some of these cookies are necessary for the proper functioning of this website (functional cookies) and relate to managing user preferences and website security. Functional cookies cannot be refused when you choose to visit this website. We would also like to set other – optional – cookies for user experience enhancement, website improvement and analytics. For more information on these cookies, please see our Cookie Policy. We will not deploy optional cookies unless you consent to their use. To grant your consent to all optional cookies at once, please click on the “Accept” button below. If you click on “Deny all” or if you close this banner without specifying your preference, we will not set any optional cookies on your device. To manage your cookie preferences, including to withdraw your consent, please refer to and adjust your browser settings as explained in our Cookie Policy, accessible here.